Theresa D amico NP

Recommended Articles

• Can Pleurisy Destroy My Lungs?

  What is pleurisy?Pleurisy is the inflammation of the thin pleural membranes that line the lungs.What happens in pleurisy?A thin membrane called the pleura lines your lungs. The pleura are double-layered membranes that line your lungs as well as the inner aspect of the chest wall. Between these...

• Rapid Shallow Breathing (Tachypnea): Causes and Treatments

  What is rapid shallow breathing?Rapid, shallow breathing, also medically called as tachypnea, is a term used to describe a breathing that is too fast, particularly when people have it due to a lung disease or other health conditions. Sometimes, rapid, shallow breathing and hyperventilation...

• Causes of Lung Nodules

  What are lung nodules?Lung nodules are spots present on the lung. These spots are usually around 1.5 inches or three centimeters in diameter. Lung nodules seen on imaging tests are often called as coin lesions. If a lung X-ray shows spots that are more than three centimeters, it is regarded as a...

• Lung Cancer : How to Treat it?

  Lung Cancer: There are two main types of lung cancer; small cell lung cancer (SCLC)  and non-small cell lung cancer (NSCLC). These two types of lung cancers are based on the way the tumors grow and spread. Lung cancer has the highest rate of death toll out of all cancers in the US. The main causes...

• What is a Lung Biopsy?

  A lung biopsy is a medical procedure which involves removal of a small piece of lung tissue to examine it closely under a powerful microscope. Lung biopsy can be done in 4 different ways. However, the method used depends solely on the overall body health and the place of the lung where the sample is...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...